Document and Entity Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address State Or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Emerging Growth Company Entity Small Business Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Amendment Flag Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line Items] Assets [Abstract] Assets Assets, Current [Abstract] Current assets Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents Short-term Investments Short-term investments Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Property and equipment, net Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Right-of-use operating lease Restricted Cash, Noncurrent Restricted cash Long-term Investments Long-term investments Intangible Assets, Net (Excluding Goodwill) Intangible assets Deposits Assets, Noncurrent Security deposits and non-current assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity Liabilities, Current [Abstract] Current liabilities Accounts Payable, Current Accounts payable Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer) Accrued Expenses And Other Liabilities, Current Accrued expenses and other liabilities Total accrued expenses and other liabilities Business Combination, Contingent Consideration, Liability, Current Contingent consideration liability, short-term Deposit Liability, Current Deposit liability Liabilities, Current Total current liabilities Operating Lease, Liability, Noncurrent Operating lease liability, long term Deferred Income Tax Liabilities, Net Deferred tax liability Liabilities Total liabilities Members' equity: Stockholders' equity: Common Unit, Issuance Value Common stock, $0.0001 par value, 300,000,000 shares authorized; 180,102,343 and 87,519,096 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Members' Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Stockholders' Equity Attributable to Parent Ending balance Beginning balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, issued Common Stock, Shares, Outstanding Common stock, outstanding CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Revenue from Contract with Customer, Excluding Assessed Tax Collaboration revenue Operating expenses Less cost and expense: Research and Development Expense (Excluding Acquired in Process Cost) Research and development General and Administrative Expense. General and administrative Operating Expenses. Total operating expenses Operating Income (Loss) Income (loss) from operations Interest Income, Other Interest income Other Nonoperating Income (Expense) Other income (loss) Nonoperating Income (Expense) Total other income Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before provision for income taxes Net income (loss) Net income (loss) Earnings Per Share, Basic Net income (loss) per common share Basic (in dollars per share) Earnings Per Share, Diluted Net income (loss) per common share Diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted average common shares outstanding Basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average common shares outstanding Diluted (in shares) Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Other comprehensive income (loss) OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax Unrealized loss on investments Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income (loss) CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Common Stock Member Common Stock Additional Paid-in Capital Additional Paid-in Capital Accumulated Deficit Accumulated Deficit Accumulated Other Comprehensive Loss Other Comprehensive Income (Loss) Increase (Decrease) in Stockholders' Equity [Roll Forward] Shares, Outstanding Ending Balance (in shares) Beginning Balance (in shares) Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock upon the exercise of stock options and 2021 ESPP Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised Issuance of common stock upon the exercise of stock options and 2021 ESPP (in shares) Stock Issued During Period, Value, Restricted Stock Award, Gross Vesting of restricted stock Stock Issued During Period, Shares, Restricted Stock Award, Gross Vesting of restricted stock (in shares) Equity impact of the value of new stock and warrants issued during the period. Stock And Warrants issued during Period, Value, new Issues Issuance of common stock, warrants and pre-funded warrants, net of issuance costs of $8,588 Number of new stock and warrants issued during the period. Stock And Warrants issued during Period, Shares, new Issues Issuance of common stock, warrants and pre-funded warrants, net of issuance costs of $8,588 (in shares) Value of stock issued as a result of the vesting of early exercise of stock options Stock Issued During Period, Value, Vesting of Early Exercise Stock Options Vesting of early exercise stock options Number of stock issued as a result of the vesting of early exercise of stock options. Stock Issued During Period, Shares, Vesting of Early Exercise Stock Options Vesting of early exercise stock options (in shares) Value of stock issued as a result of the vesting of Restricted Stock Units Stock Issued During Period, Value, Restricted Stock Units Vesting of restricted stock units Shares of stock issued as a result of the vesting of Restricted Stock Units Stock Issued During Period, Shares, Restricted Stock Units Vesting of restricted stock units (in shares) OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Unrealized loss on investments APIC, Share-based Payment Arrangement, Increase for Cost Recognition Stock based compensation Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock and warrants. Adjustments to Additional Paid in Capital, Stock and Warrants Issued, Issuance Costs Net of issuance costs CONSOLIDATED STATEMENTS OF CASH FLOWS Cash flows from operating activities Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net income (loss) Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income (loss) to net cash used in operating activities: Depreciation Depreciation Represents amount of non-cash operating lease expense. Non Cash Operating Lease Expense Non-cash operating lease expense (benefit) Share-based Payment Arrangement, Noncash Expense Stock based compensation Accretion (Amortization) of Discounts and Premiums, Investments Accretion of investments Amount of gain in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Business Combination, Contingent Consideration Arrangements, Gain in Amount of Contingent Consideration, Liability Change in fair value of contingent liabilities Change in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Operating Lease Liability Operating lease liability Increase (Decrease) in Deferred Revenue Deferred revenue Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other liabilities Increase (Decrease) in Security Deposits Security deposit Net Cash Provided by (Used in) Operating Activities Cash used in operations Net cash used in operating activities Cash flows from investing activities Payments to Acquire Property, Plant, and Equipment Acquisition of property and equipment Payments to Acquire Debt Securities, Available-for-sale Acquisition of fixed maturity securities, available for sale Proceeds from Sale of Debt Securities, Available-for-sale Sale of fixed maturity securities, available for sale Net Cash Provided by (Used in) Investing Activities Net cash provided (used in) by investing activities Cash flows from financing activities Proceeds from Issuance of Common Stock Proceeds from issuance of common stock and ESPP The cash inflow from PIPE, net of proceeds. Proceeds from PIPE, net of issuance costs Proceeds from PIPE, net of issuance costs Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net decrease in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents and restricted cash, end of period Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents, and restricted cash Supplemental disclosure of cash and non-cash operating activities: Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Recognition of ROU asset and lease liability at lease commencement Cash paid for income tax Cash paid for income tax Amount of supplemental disclosure of cash and non-cash operating activities. Supplemental Disclosure of Cash and Non-Cash Operating Activities Total supplemental disclosure of cash and non-cash operating activities Organization and description of the business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization and description of the business Summary of significant accounting policies and basis of presentation Basis of Presentation and Significant Accounting Policies [Text Block] Summary of significant accounting policies and basis of presentation Financial instruments and fair value measurements Fair Value Disclosures [Text Block] Financial instruments and fair value measurements Property and equipment, net Property, Plant and Equipment Disclosure [Text Block] Property and equipment, net Accrued expenses and other liabilities. Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued expenses and other liabilities Bristol-Myers Squibb Collaboration Revenue from Contract with Customer [Text Block] Bristol-Myers Squibb Collaboration Commitments and contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and contingencies Leases Leases of Lessee Disclosure [Text Block] Leases Income taxes Income Tax Disclosure [Text Block] Income taxes Basic and diluted net income (loss) per common share Earnings Per Share [Text Block] Basic and diluted net income (loss) per common share Defined contribution plan Defined Contribution Plan [Text Block] Defined contribution plan Stock-based compensation Share-based Payment Arrangement [Text Block] Stock-based compensation Common Stock Equity [Text Block] Common Stock Segment Reporting Segment Reporting Disclosure [Text Block] Segment Reporting Subsequent Events Subsequent Events [Text Block] Subsequent Events Basis of Accounting, Policy [Policy Text Block] Basis of presentation Use of Estimates, Policy [Policy Text Block] Use of estimates Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of credit risk and other risks and uncertainties Fair Value Measurement, Policy [Policy Text Block] Fair value of financial instruments Cash and Cash Equivalents, Policy [Policy Text Block] Cash and cash equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Restricted cash Disclosure of accounting policy for fixed maturity securities. Fixed Maturity Securities Policy [Policy Text Block] Investments Property, Plant and Equipment, Policy [Policy Text Block] Property and equipment, net Research and Development Expense, Policy [Policy Text Block] Research and development expenses Share-based Payment Arrangement [Policy Text Block] Stock-based compensation Disclosure of accounting policy for warrants. Warrants Policy [Policy Text block] Warrants Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign currency translation Earnings Per Share, Policy [Policy Text Block] Basic and diluted net income (loss) per common share Disclosure of accounting policy for acquisition-related contingent considerations. Acquisition-Related Contingent Considerations [Policy] Acquisition-Related Contingent Consideration Business Combinations Policy [Policy Text Block] Business Combinations Goodwill and Intangible Assets, Policy [Policy Text Block] Intangible Assets New Accounting Pronouncements, Policy [Policy Text Block] Recent accounting pronouncements Schedule of Cash and Cash Equivalents [Table Text Block] Schedule of reconciliation of the Company's cash, cash equivalents, and restricted cash Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Schedule of assets measured at fair value by level within the fair value hierarchy Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Schedule of investments in fixed maturity securities Investments Classified by Contractual Maturity Date [Table Text Block] Schedule of maturities of fixed maturity available-for-sale securities Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Schedule of contingent consideration liabilities Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of inputs in company's contingent consideration liabilities Property, Plant and Equipment [Table Text Block] Schedule of summary of property and equipment, net Schedule of Accrued Liabilities [Table Text Block] Schedule of summary of accrued expenses Lease, Cost [Table Text Block] Schedule of components of lease expenses Schedule of supplemental balance sheet information related to leases. Schedule of Supplemental Balance Sheet Information related to leases Tabular disclosure of supplemental information related to leases. Schedule of Supplemental Information Related to Leases [Table Text Block] Schedule of supplemental lease term and discount rate information related to leases Schedule of supplemental cash flow information related to leases. Schedule of Supplemental Cash Flow Information Related to Leases Schedule of supplemental cash flow information related to leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of Future minimum lease payments of operating leases Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potential shares of common stock excluded Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Restricted stock units Restricted stock units Unvested restricted stock units Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock-based compensation Tabular disclosure of shares reserved for issuance under share-based payment arrangement. Share-Based Payment Arrangement, Shares Reserved for Issuance [Table Text Block] Schedule of reserved shares of common stock Tabular disclosure of shares available for grant for award under share-based payment arrangement. Share-Based Payment Arrangement, Shares Available for Grant [Table Text Block] Schedule of common stock available under 2021 Incentive Plan Share-based Payment Arrangement, Option, Activity [Table Text Block] Schedule of stock option activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of weighted-average assumptions Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. Schedule of Stock-based Compensation Expense Recorded Under ASC 718 [Table Text Block] Schedule of Stock-based compensation expense recorded under ASC 718 Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of stock-based compensation expense and by award type Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of restricted stock activity Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of breakdown of research and development expenses to assess performance and allocate resources Schedule of Capitalization, Equity [Table] Schedule of Capitalization, Equity [Line Items] Organization and description of the business Amount of cash and cash equivalents on short and long term investments. Cash And Cash Equivalents Short And Long Term Investments Amount of cash and cash equivalents on short and long term investments Sale of Stock, Consideration Received on Transaction Net proceeds Restricted Cash Restricted cash in cash on deposit to secure certain lease commitments Amount of cash restricted included in prepaids and other current assets. Restricted Cash Included in Prepaid and Other Current Assets Restricted cash included in prepaid and other current assets Property, Plant and Equipment, Useful Life Estimated useful lives of the assets Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend rate Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Impairment of indefinite-lived intangibles Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Level 1 Level 1 Level 2 Level 2 Level 3 Level 3 Financial Instrument [Axis] Financial Instruments [Domain] U.S. Treasury U.S. Treasury Corporate bonds Corporate bonds Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Financial instruments and fair value measurements Assets, Fair Value Disclosure [Abstract] Assets: Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Debt Securities, Available-for-Sale, Excluding Accrued Interest, Noncurrent Debt securities Assets, Fair Value Disclosure Total assets Liabilities, Fair Value Disclosure [Abstract] Liabilities: Business Combination, Contingent Consideration, Liability Contingent consideration Financial Liabilities Fair Value Disclosure Ending balance Beginning balance Total liabilities Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2. Fair Value, Assets, Level 1 to Level 2 Transfers, Amount One Transfer of assets from level 1 to level 2 Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1. Fair Value, Assets, Level 2 to Level 1 Transfers, Amount One Transfer of assets from level 2 to level 1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net Transfer of assets from or to level 3 Amount of transfers of liabilities measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2. Fair Value, Liabilities, Level 1 to Level 2 Transfer, Amount Transfer of liabilities from level 1 to level 2 Amount of transfers of liabilities measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1. Fair Value, Liabilities, Level 2 to Level 1 Transfer, Amount Transfer of liabilities from level 2 to level 1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Transfer of liabilities from or to level 3 Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-sale [Line Items] Financial instruments and fair value measurements Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss, Current Amortized Cost Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Debt Securities, Available-for-Sale, Excluding Accrued Interest Fair Value Debt securities Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Less than one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five One to five years Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Number of available-for-sale investment debt securities Debt Instrument, Increase (Decrease), Net Amount of accrued interest receivable on available-for-sale investment debt securities NA Gadeta contingent consideration Gadeta NA Holdback contingent consideration Holdback Shares NA Milestone contingent consideration Milestone Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Changes in fair value Fair Value Measurement Inputs and Valuation Techniques [Table] Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement input using probability adjusted value of milestone payments. Measurement Input, Milestone Payment Probability Adjusted Value [Member] Probability adjusted value of payments Discount Rate Discount rate Measurement input using discount period. Discount period Discount period (years) Fair Value Measurement Inputs and Valuation Techniques [Line Items] Business Combination, Contingent Consideration, Liability, Measurement Input Contingent consideration liability, Measurement input Property, Plant and Equipment [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Domain] Represents information pertaining to lab equipment. Lab equipment Lab equipment Leasehold improvements Leasehold improvements Construction in progress Construction in progress Computer software and equipment Computer software and equipment Furniture and fixtures Furniture and fixtures Property, Plant and Equipment [Line Items] Property and equipment, net Leases Property, Plant and Equipment, Gross Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: Accumulated depreciation Employee-related Liabilities, Current Payroll and bonuses Carrying value as of the balance sheet date of obligations incurred through that date for A\accrued clinical trial related costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued clinical trial related costs Accrued clinical trial related costs Accrued Professional Fees, Current Professional and legal fees Operating Lease, Liability, Current Operating lease liability, current Operating lease liability, current Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Represents the information pertaining to Bristol Myers Squibb Company Collaboration Agreement. Collaboration Agreement Collaboration agreement Product and Service [Axis] Product and Service [Domain] This member standards for option rights Option rights Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Bristol-Myers Squibb Collaboration Stock Issued During Period, Shares, New Issues Common stock issued Contract with Customer, Liability, Revenue Recognized Cumulative collaboration revenue recognized The amount of revenue to be recognized in future. Revenue to be Recognized in Future Future collaboration revenues Loss Contingencies [Table] Other Commitments [Axis] Other Commitments [Domain] Represents the information pertaining to Distributed bio master agreement. Distributed Bio Master Service Agreement Represents the information pertaining to iCELL Inc. Sublicense Agreement. iCELL Inc. Sublicense Agreement Represents information pertaining to Catalent Dusseldorf GmbH license agreement. Catalent Dusseldorf GmbH License Agreement [Member] Catalent Dusseldorf GmbH License Agreement Related Party Transaction [Axis] Related Party Transaction [Domain] Represents the information pertaining to FCDI Collaboration Agreement. FCDI Collaboration Agreement FCDI Collaboration Agreement Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum Maximum Balance Sheet Location [Axis] Balance Sheet Location [Domain] Obligations incurred and payable to current vendors for goods and services received. Accounts Payable Current [Member] Accounts payable current Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Refers to Clade Therapeutics, Inc. acquisition. Clade Therapeutics, Inc. Clade Therapeutics, Inc Loss Contingencies [Line Items] Commitments and contingencies The amount of upfront cash payment receivable under the collaboration agreement. Collaboration Agreement, Upfront Cash Payment, Receivable Upfront cash payment receivable Related Party Transaction, Amounts of Transaction Payment to related party Research and Development Expense Research and development Amount of milestone payment. Commitment, Milestone Payments Milestone payments The amount of milestone payments due in collaborative arrangement. Collaborative Arrangement, Milestone Payments, Payable Milestone payments due Other Commitment Accrued expenses Amount of development and regulatory approval milestone payments. Development And Regulatory Approval Milestone Payments Development and regulatory approval milestone payments The amount of milestone payments due for product type one for license agreement. License Agreement, Milestone Payment to be Made By Product Type One License agreement milestone payment type one The amount of milestone payments due for product type two for license agreement. License Agreement, Milestone Payment to be Made By Product Type Two License agreement milestone payment type two The cash outflow during the period as milestone payments under the license agreements. License Agreement, Milestone Payments Milestone payments under the license agreements Minimum Minimum Refers to security deposits on certain leases. Security Deposits on Leases Amount of security deposits on certain leases Amount of reduction in operating lease right of use asset due to lease modification during the period. Operating Lease Right Of Use Assets Decrease From Modification Operating lease right of use assets decrease from modification Amount of reduction in operating lease liability due to lease modification during the period. Operating Lease Liability Decrease From Modification Operating lease liability decrease from modification Gain (Loss) on Termination of Lease Gain on reduction in lease liability due to lease termination Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Reduction of ROU asset and lease liability due to non-cash lease modification Lessee, Operating Lease, Term of Contract Lessee, operating lease, term of contract Asset Impairment Charges Impairment of long-lived assets Lessee, Operating Lease, Liability, to be Paid Total lease payments Future minimum lease payments Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Leases Lease, Cost [Abstract] Operating lease expense: Operating Lease, Cost Fixed lease cost Variable Lease, Cost Variable lease cost Lease, Cost Total operating lease expense Operating Lease, Liability Total Total operating lease liability Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease terms (years) - operating leases Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate - operating leases Supplemental Cash Flow Information [Abstract] Supplemental cash flow information Proceeds from Lease Payment, Operating Activity Operating cash flows from operating leases Lessee, Operating Lease, Liability, Payment, Due [Abstract] Operating Leases Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four 2030 Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Lessee Operating Lease Liability Payments Due After Year Four Thereafter Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: Imputed interest Income Tax Examination [Table] Income Tax Examination [Line Items] Income Tax Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Tax benefit incurred for operating losses Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Equity Option [Member] Stock options to purchase common stock Represents information pertaining to early exercised stock options subject to future vesting. Early Exercised Stock Options Subject To Future Vesting [Member] Early exercised stock options subject to future vesting Warrant [Member] Warrants Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Basic and diluted net income (loss) per common share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities excluded from the computation of diluted net loss per share Defined Contribution Plan [Table] Scenario [Axis] Scenario [Domain] Represents the information pertaining to first 3% of participating employee contributions First 3% of participating employee contributions Represents the information pertaining to next 2% of participating employee contributions Next 2% of participating employee contributions Defined Contribution Plan Disclosure [Line Items] Defined contribution plan Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Employer contribution matching percentage Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Employee contribution Defined Contribution Plan, Cost Defined contributions Stock options Plan Name [Axis] Plan Name [Domain] Refers to the 2021 Incentive Plan 2021 Incentive Plan 2021 Incentive Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Shares authorized for issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Ending balance Beginning balance Shares available for grant Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Stock reserved for issuance upon the exercise of previously granted stock options Additional shares authorized for issuance under share-based payment arrangement as percent of shares outstanding. Share-Based Compensation Arrangement by Share-Based Payment Award, Additional Shares Authorized as Percent of Outstanding Shares Percentage of common stock outstanding Increase in aggregate number of common shares reserved for issuance. Increase in Common Stock, Capital Shares Reserved for Future Issuance Increase in common stock reserved Shares reserved for issuance Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Stock awards vesting period Restricted stock vesting period Represents information pertaining to employee stock options and restricted stock units. Employee Stock Options and Restricted Stock Units [Member] Options and RSUs Employee stock purchase plan Employee stock purchase plan The number of shares under options and equity-based payment instruments other than stock options outstanding. Share-Based Compensation Arrangement by Share-Based Payment Award, Options and Equity Instruments Other than Options, Outstanding Options and RSUs issued and outstanding Common Stock, Capital Shares Reserved for Future Issuance Reserved shares of common stock for issuance Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Options granted Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period RSU's granted Granted The number of shares under options and equity-based payment instruments other than stock options, that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements. Share-Based Compensation Arrangement by Share-Based Payment Award, Options and Equity Instruments Other than Options, Forfeitures in Period Options and RSUs forfeited / cancelled Represents information pertaining to time based vesting. Time Based Vesting Time Based Vesting Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding, ending (in shares) Outstanding, beginning (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding, ending Outstanding, beginning Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted Average Remaining Contractual Term (years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract] Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Outstanding, ending Outstanding, beginning Amount of difference between fair value of the underlying shares and the exercise price of options granted. Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Intrinsic Value Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Intrinsic value of options exercised Exercised Amount of difference between fair value of the underlying shares and the exercise price of options that were forfeited during the period. Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period, Intrinsic Value Forfeited Amount of difference between fair value of the underlying shares and the exercise price of options that were cancelled during the period. Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Cancellations In Period, Intrinsic Value Cancelled Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized compensation expense Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized compensation expense expected to be recognized over a weighted average period Unrecognized compensation expense expected to be recognized over a weighted average period weighted-average assumptions fair value of stock option granted Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected option term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Restricted stock Restricted stock awards subject to future vesting Restricted stock awards Income Statement Location [Axis] Income Statement Location [Domain] Research and development Research and development General and administrative General and administrative Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Stock-based compensation Share-based Payment Arrangement, Expense Total stock-based compensation Represents the information pertaining to unvested restricted stock unit with time based vesting. Unvested Restricted Stock Unit With Time Based Vesting [Member] Unvested restricted stock unit with time-based vesting Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Total Unvested Total Unvested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Total Unvested Total Unvested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized compensation expense Refers to the 2021 Employee Stock Purchase Plan Employee Stock Purchase Plan 2021 Employee Stock Purchase Plan 2021 Schedule of Stock by Class [Table] Refers to 2024 Sales Agreement Sales Agreement Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to at the market offering. At the Market Offering [Member] At the market offering Private Placement [Member] 2026 Private Placement Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents information pertaining to common warrants. Common Warrants [Member] Common Warrants Represents information pertaining to pre-funded warrants. Pre-funded Warrants [Member] Pre-funded Warrants Represents information pertaining to common warrants accompanied with pre-funded warrants. Common Warrants Accompanied With Pre-funded Warrants [Member] Common warrants accompanied with pre-funded warrants Class of Stock [Line Items] Common Stock Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants to purchase units Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants exercise price Represents the combined offering price of each share of common stock and accompany common stock warrant. Combined Offering Price of Each Share of Common Stock and Common Stock Warrant Combined offering price of each share of common stock Offering price per share or per unit of warrants or rights issued. Class of Warrant or Right, Price of Warrants or Rights Offering price per share Warrants and Rights Outstanding, Term Warrants term Number of Operating Segments Number of reportable segment not disclosed Number Of Reportable Segments Not Disclosed [Flag] Number of reportable segment not disclosed Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] Represents information pertaining to single reportable segment. Single Reportable Segment [Member] Single reportable segment Segment Reporting Information [Line Items] Segment Reporting Research and Development Expense [Abstract] Research and development Labor and Related Expense Personnel and related costs Amount of facility and other allocated costs. Facility And Other Allocated Costs Facility and other allocated costs Amount of research and laboratory expense. Research And Laboratory Expense Research and laboratory Other Research and Development Expense Other research and development Segment Reporting, Other Segment Item, Amount Other segment (income) expense Segment Reporting, Other Segment Item, Composition, Description Segment reporting other item description Refers to the trading plan one. Trading Plan One [Member] Trading Plan 1 Refers to the trading plan two. Trading Plan Two [Member] Trading Plan 2 Represents information of Gregory Russotti. Gregory Russotti [Member] Gregory Russotti